January 8th 2025
The FDA approved the addition of Guillain-Barré syndrome warnings for Abrysvo and Arexvy, citing postmarketing data suggesting an increased risk.
January 7th 2025
The first death of an American from the H5N1 virus was reported in Louisiana on Monday, though authorities maintain the risk of widespread infection remains low.
January 6th 2025
Sanofi and SK bioscience expand collaboration on pneumococcal conjugate vaccines, including a 21-valent candidate for pediatric populations.
December 18th 2024
Your daily dose of the clinical news you may have missed.
December 10th 2024
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 19, 2021
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 16, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 15, 2021
New Evidence Reveals Most Common Long-term COVID-19 Symptoms among Health Care Workers
Fatigue was among the most common symptoms that health care workers in Sweden reported 8 months after mild COVID-19 infection, according to a new research letter.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 14, 2021
Single Injection of Monoclonal Antibodies Reduces Risk of Symptomatic SARS-CoV-2 Infection
A single injection of casirivimab and imdevimab reduced the risk for symptomatic SARS-CoV-2 infection by 81% among household contacts of infected persons, according to new phase 3 study results.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 13, 2021
FDA/CDC Recommend Pause on J&J Vaccine Use After Reports of Blood Clots
Reports of a rare, severe type of blood clot in 6 women in the US led the agencies to halt use of the J&J product, out of an abundance of caution.
NAFLD & NASH in Primary Care: Facts, Definitions, & Figures in Brief
Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis is increasing and early detection is critical. Brush up on basics with our slides.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 12, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 9, 2021
Global confirmed cases of COVID-19 have surpassed 134 million. Plus more data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
Long COVID Review Lead Author Highlights Knowns, Unknowns
Long COVID is now a term recognized worldwide. We talked with Ani Nalbandian, MD, lead author of the most comprehensive review-to-date, about what she and her colleagues have learned.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 8, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 7, 2021
COVID-19 Death Rates Far Higher for Black Women vs Men in Other Racial Groups, Suggest Harvard Researchers
Black women in the US are dying from COVID-19 at a higher rate than every other sex and racial group, except Black men, according to a new study.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 6, 2021
ACP Guidance on Antibiotic Use: 4 Conditions Ideal for Short-course Treatment
Longer antibiotic treatment courses can often be safely and effectively shortened, according to the ACP guidance; 4 common conditions serve as examples.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 5, 2021
FDA Increased the Maximum Doses per Vial for Moderna COVID-19 Vaccine
In an April 1, 2021 statement, the FDA announced the authorization of a new multi-dose vial of Moderna's COVID-19 vaccine that contains up to 15 doses.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 2, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 1, 2021
Pfizer-BioNTech COVID Vaccine Efficacy High at 6 Months, Companies Report
The COVID-19 vaccine partners announced an efficacy rate of >90% for BNT162b2 among 12 000 trial participants at up to 6 months after the second dose.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of March 31, 2021
Pfizer-BioNTech COVID-19 Vaccine Found 100% Effective in Younger Teens
Pfizer-BioNTech announced today the complete protection against infection with SARS-CoV-2 among youth aged 12 to 15 years.
SARS-CoV-2 Variants: How Many and How Dangerous?
The CDC defines 3 classes of SARS-CoV-2 variants: Variants of interest, of concern, and of high consequence. Find out more about the 8 variants now being closely observed.
COVID-19 Updates: US and Global Cases, Deaths, and Vaccinations as of March 30, 2021
COVID-19: Bamlanivimab-Etesevimab Antibody Cocktail Reduces Risk of Hospitalization, Death
New data suggests that the antibody cocktail, bamlanivimab plus etesevimab, reduces the risk of COVID-19-related hospitalizations and death by 87% in high-risk COVID-19 patients.
COVID-19 Vaccination Stats: Frontline Health Care Workers
Survey: Slightly more than one-half of US frontline healthcare workers have received at least 1 dose of a COVID-19 vaccine. But some still plan not to get vaccinated at all.
COVID-19 Updates: US and Global Cases, Deaths, and Recoveries as of March 29, 2021
COVID-19 Updates: US and Global Cases, Deaths, and Recoveries as of March 26, 2021
US confirmed cases of COVID-19 have surpassed 30 million; global cases have reached 125 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.